According to AlphaMoat, in July 2026 menten.AI (menten.ai) received 0 monthly visits — ranked #0 of 17,609 AI websites with traffic data, and #0 of 3,112 in Industry Services; its largest market is United States (52.9% of visits).
Menten AI is a company using generative AI for peptide drug design; its MAUD 1.0 platform rapidly creates macrocyclic peptides with oral bioavailability and cell permeability, partnering with the world's top 10 pharma companies.
| Month | Monthly visits | MoM |
|---|---|---|
| 2025-08 | 2.2K | +49.9% |
| 2025-09 | 1.6K | -26.7% |
| 2025-10 | 1.8K | +11.2% |
| 2025-11 | 2.1K | +16.1% |
| 2025-12 | 2.2K | +4.4% |
| 2026-01 | 890 | -59.6% |
| 2026-02 | 1.5K | +71.2% |
| 2026-03 | 2.0K | +31.2% |
| 2026-04 | 3.8K | +92.3% |
| 2026-05 | 3.4K | -12.0% |
| 2026-06 | 1.5K | -56.7% |
| 2026-07 | 2.1K | +43.8% |
An AI recruiting platform unifying hiring workflows, talent relationships, and analytics.
+ CompareA platform connecting specialists with model research, training, and evaluation projects
+ CompareA conversational hiring agent that moves candidates from application through onboarding
+ CompareA talent-intelligence platform using agents to support hiring, development, and workforce deployment
+ CompareA clinician platform combining communication, telehealth, and AI-assisted documentation
+ CompareAn AI research and search platform built for professional investors
+ CompareData month: 2026-07 · Visit figures are third-party traffic estimates aggregated monthly — best for scale and trends. Multiple domains of the same product are merged. See methodology.